Figuera-Figuera, A.; Suñé-Pou, M.; Pérez-Lozano, P.; GarcÃa-Montoya, E.; Amela-Navarro, J.; Suñé-Negre, J.M.
SeDeM as a Tool to Validate Drug Substance Manufacturing Processes and Assess Scalability and Suitability for Direct Compression: Supplier Screening. Pharmaceutics 2023, 15, 2034.
https://doi.org/10.3390/pharmaceutics15082034
AMA Style
Figuera-Figuera A, Suñé-Pou M, Pérez-Lozano P, GarcÃa-Montoya E, Amela-Navarro J, Suñé-Negre JM.
SeDeM as a Tool to Validate Drug Substance Manufacturing Processes and Assess Scalability and Suitability for Direct Compression: Supplier Screening. Pharmaceutics. 2023; 15(8):2034.
https://doi.org/10.3390/pharmaceutics15082034
Chicago/Turabian Style
Figuera-Figuera, Alba, Marc Suñé-Pou, Pilar Pérez-Lozano, Encarna GarcÃa-Montoya, Joaquim Amela-Navarro, and Josep M. Suñé-Negre.
2023. "SeDeM as a Tool to Validate Drug Substance Manufacturing Processes and Assess Scalability and Suitability for Direct Compression: Supplier Screening" Pharmaceutics 15, no. 8: 2034.
https://doi.org/10.3390/pharmaceutics15082034
APA Style
Figuera-Figuera, A., Suñé-Pou, M., Pérez-Lozano, P., GarcÃa-Montoya, E., Amela-Navarro, J., & Suñé-Negre, J. M.
(2023). SeDeM as a Tool to Validate Drug Substance Manufacturing Processes and Assess Scalability and Suitability for Direct Compression: Supplier Screening. Pharmaceutics, 15(8), 2034.
https://doi.org/10.3390/pharmaceutics15082034